1. 首頁 > 健康養生 > >

特征|《細胞》子刊：預測免疫療效的標志物輪到你了，漿細胞！( 三 )

腫瘤細胞特征漿細胞B細胞預測療效免疫基因治療患者研究標志物


參考文獻：
[1] Duma N, Santana-Davila R, Molina JR. Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment. Mayo Clin Proc. 2019;94(8):1623-1640. doi:10.1016/j.mayocp.2019.01.013
[2] Mok TSK, Wu YL, Kudaba I, et al. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial. Lancet. 2019;393(10183):1819-1830. doi:10.1016/S0140-6736(18)32409-7
【特征|《細胞》子刊：預測免疫療效的標志物輪到你了，漿細胞！】[10] Adler LN, Jiang W, Bhamidipati K, et al. The Other Function: Class II-Restricted Antigen Presentation by B Cells. Front Immunol. 2017;8:319. Published 2017 Mar 23. doi:10.3389/fimmu.2017.00319